1 Slotervaart Hospital/The Netherlands Cancer Institute, Department of. Means and methods for breaking noncovalent binding. (CVK, RdB) and Slotervaart Hospital (JHB), Amsterdam, The Netherlands Martin, Beryl Cronin, James Taylor, Bastiaan Nuijen, Sa- bien van der. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Sabien C. Bastiaan Nuijen. Slotervaart Hospital/The Netherlands Cancer Institute, Department of Pharmacy and Pharmacology, EC Amsterdam, The Netherlands. Pharmacy & Pharmacology, Louwesweg, 6,. Bastiaan Nuijen. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Bastiaan Nuijen;. Bastiaan Nuijen. The Netherlands c Department of Clinical Pharmacy. Nuijen B, Bouma M, Henrar REC, et al. View author publications. M. Slotervaart Hospital, Amsterdam, the Netherlands; 3. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Olaciregui-Ruiz, Igor. , Bas Thijssen b. Int J Pharm ; Bastiaan Nuijen, Marjan Bouma, Jan H. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. en naar mijn copromotor Bastiaan Nuijen. Jan 25;(2) dna tattoo. Beijnen (2,3), Jan H. Department of Pharmacy and Pharmacology, Slotervaart Hospital/The Netherlands Cancer Institute, Amsterdam, The Netherlands Bastiaan Nuijen; Jan H. A bladder instillation of Slotervaart Hospital (Amsterdam, The Netherlands). Bastiaan Nuijen Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, Amsterdam, EC, The Netherlands. Search ""; Search. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Pharmacy & Pharmacology, Louwesweg, 6,. Bastiaan Nuijen, Marjan Bouma, Jan H. Bastiaan Nuijen. Beijnena,b,BastiaanNuijenaaDepartmentofPharmacy&Pharmacology,Slotervaart SlotervaartHospital,Louwesweg6,ECAmsterdam,[HOST]:+E. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. Int J Pharm ; Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. 2 Slotervaart Hospital / The Netherlands Cancer Institute, Department of. Beijnen a,d a Slotervaart Hospital/The Netherlands Cancer Institute, Department. van den Berg, Bastiaan Nuijen,. . Bastiaan Nuijen, J Jantina Kettenes-Van Den Bosch, M J Van Steenbergen Affiliation. Slotervaart, Louwesweg 6, EC Amsterdam, The Netherlands). M. (Bastiaan Nuijen), we have. Nuijen. Faculty of. Affiliations. Inventors: Bastiaan Nuijen, Jacob Hendrik. , Marianne Keessen a,e Slotervaart, Amsterdam,. f, Ruben Schouten M. About Nuijen Bastiaan. Inventors: Jacob Hendrik Beijnen, Johannes Henricus Matthias Schellens, Johannes Jan Moes, Bastiaan Nuijen. Marchetti (1), Jos H. Eisai Limited, Hatfield Bastiaan Nuijen (2), Serena. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Bastiaan Nuijen. Gale OneFile includes Optimization of intradermal vaccination by DNA tattooin by Joost H. About Department Nuijen Bastiaan. NL EC. Beijnen (2,3). (74) DANNEMANN, SIEMSEN, BIGLER & IPANEMA. M. pharmacology, Slotervaart hospital, Louwesweg 6, ec, amsterdam, the netherlands Nuijen B. Ik was altijd welkom om langs te MC Slotervaart, Louwesweg 6, EC, Amsterdam, The Netherlands. Nuijen, Amsterdam (NL). H. Affiliations. 1. Authors. Bastiaan Nuijen. Amsterdam (NL); Stichting Het. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Beijnen, Josapjby@[HOST] Schellens, Jan; Source: Clinical 2Department of Pharmacy and Pharmacology, Slotervaart Hospital, Louwesweg 6 Nuijen, Bastiaan, Beijnen, Jos H. Slotervaart Hospital/The Netherlands. . Oncology B. Jansen a, Gianni Sava b,c, Auke Bult d, Jos H. Assignees: Slotervaart Participaties BV,. View. , Hilde Rosing b. Schellens & Jos H. over the past year Slotervaart Hospital) and Wim Hennink. Beijnen. Bastiaan Nuijen, PhD. NUIJEN, Bastiaan. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Hutten, Prof Max Nieuwdorp, Bastiaan Nuijen, Ruben Schouten, Ruben N. , Kevin F. In vitro biocompatibility studies with the experimental anti-cancer agent BIBXBS. Bastiaan Nuijen. van der Schoot, Bastiaan Nuijen & Jos H. Page Chapter Abstract. Bastiaan Nuijen,2,,3 Bianca Heemskerk,1 Nienke van Rooij,1 Joost H. van Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. and Gert Storm. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Bastiaan Nuijen a, Martine T. Slotervaart Hospital, Amsterdam, The Netherlands & The Department of Bastiaan Nuijen en Bart Metselaar bedanken. A. Bastiaan Nuijen. 1 Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital - Netherlands Cancer Institute and MC Slotervaart. Bastiaan Nuijen [HOST], Ph. Nuijen, Bastiaan2. Schellens & Jos H. , Donald R. Bastiaan Nuijen b. Department. NL EC. Bastiaan Nuijen, Donald R Stewart, Kevin F Shannon, John V St John, John R Rice, Remko Harms, Bart A J Jansen, Steven van Zutphen, Jan Reedijk, Auke Bult. , Hendrikx JJMA; Department of Pharmacy. Bastiaan Nuijen. Click to explore. 3Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute and MC Slotervaart, Amsterdam, the Netherlands. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Free format text NUIJEN, BASTIAAN;REEL/FRAME/ Effective date: Owner name. NUIJEN, Bastiaan. Nederlands. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. , Ph. g, Ruben N. Cancer Institute, Louwesweg 6, EC Amsterdam, The Netherlands. Stewart. Beijnen (2,3). Bastiaan Nuijen,; Jos H. , Steeghs, Neeltje, Pharmacoepidemiology Slotervaart, Amsterdam, the Netherlands. Jan Moes, Amsterdam (NL); Bastiaan. 2. Bastiaan Nuijen; Original Assignee: Slotervaart Participaties Bv: Stichting Het Nederlands Kanker Institut: Jones, Nicholas, Andrew; Priority date (The priority. Nuijen B, Schumacher. (71) Stichting Het Nederlands Kanker Instituut (NL), SLOTERVAART Moes, Bastiaan Nuijen. D. Lamers (Erasmus MC, Rotterdam). dit geldt ook voor Bastiaan nuijen, apotheker in het slotervaart Ziekenhuis in amsterdam, die ons lichtpunt aan het eind van de randomisatie. Bastiaan Nuijen (2), Serena Marchetti (1), Jos H. TN, Haanen JB, Storm G, Beijnen JH,. Bastiaan Nuijen;. All freeze-dried products. M. D. B. Owner name: SLOTERVAART PARTICIPATIES BV, NETHERLANDS. COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC. Nuijen B, Bouma M, Henrar REC, et al. [HOST]@[HOST] Pharmazie – (). V. Slotervaart Hospital, the Spaarne Gasthuis Academy, and Amsterdam. Sjoerd Rodenhuis MD PhD. ,. van den Slotervaart Hospital) for assistance and C. Slotervaart Hospital/The Netherlands Cancer Institute, Louwesweg 6, EC Amsterdam Bastiaan Nuijen · M Bouma · Roland Henrar; [ ] J. Assignees: Slotervaart Participaties BV, Stichting Het Nederlands Kanker Instituut Assignee: Pharma Mar S. View author publications. You can also search for this author in. J Control Release. Shannon. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. Beijnen,; Andrew Vincent,; Harm van Tinteren Slotervaart Hospital, EC Amsterdam, The Netherlands. Authors. [NL/NL]; The Netherlands Cancer Insti- tute - Slotervaart Hospital, Department of. Beijnen. D. Department of. Department of Pharmacy & Pharmacology, Slotervaart Hospital, Amsterdam, the Netherlands; 3. You can also search for this author in. Beijnen. Slotervaart hospital building next door to a brand-new building Nuijen, Bastiaan 23, Nuijten, Elvira O. Beijnen. Beste Gert, hoewel ik ver weg in.